Cryoport, Inc. - Director's Dealing 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2021-02-25

Reporting Person: Sawicki Mark W (Chief Scientific Officer)

Security	Shares	Ownership
Common Stock	19000	Direct

Security	Exercise Price	Expiration	Underlying	Ownership
Option to purchase common stock	$3.07	2025-08-20	Common Stock (11342)	Direct
Option to purchase common stock	$1.87	2026-05-06	Common Stock (7231)	Direct
Option to purchase common stock	$8.65	2028-03-28	Common Stock (68000)	Direct
Option to purchase common stock	$12.79	2029-04-01	Common Stock (90000)	Direct
Option to purchase common stock	$16.93	2030-03-30	Common Stock (100000)	Direct
Option to purchase common stock	$3.21	2027-05-18	Common Stock (11831)	Direct
Option to purchase common stock	$7.80	2025-05-07	Common Stock (77625)	Direct

F1: 1/48th of the 156,400 options originally granted vested on the 19th of each month for forty-eight months beginning September 19, 2015.

F2: 1/48th of the 70,000 options originally granted vested on the 6th of each month for forty-eight months beginning June 6, 2016.

F3: 1/48th of the 68,000 options originally granted vested on the 28th of each month for forty-eight months beginning April 28, 2018.

F4: 1/48th of the 90,000 options originally granted vested on the 1st of each month for forty-eight months beginning May 1, 2019.

F5: 1/48th of the 100,000 options originally granted vested on the 30th of each month for forty-eight months beginning April 30, 2020.

F6: 1/48th of the 78,000 options originally granted vested on the 18th of each month for forty-eight months beginning June 18, 2017.

F7: 1/48th of the 77,625 options originally granted vested on the 7th of each month for forty-eight months beginning June 7, 2015.